Home      Site Map      Contact Us      Legal Terms      Privacy Policy   
TRUSTEES
Dr. Paul Lizardi, Professor of Pathology at Yale University, and co-founder, director and chairman, Scientific Advisory Board of Agilix Corporation

• Dr. Lizardi is a professor of pathology, biophysics and molecular biochemistry in the Department of Pathology at Yale University’s School of Medicine.

• He is considered one of the leading experts in the study of cancer genetics and epigenetics, the study of reversible changes in genetic regulation. He is also well known for his technological innovations in the amplification of DNA.


• The work conducted in his laboratory has generated more than 30 patents in the field of Rolling Circle Amplification Technology (RCAT), in signal/guide molecular technology, the amplification of isothermal genomes, and GenCompass technology.

• His lab has also made significant contributions in the fields of cancer diagnostics and the development of therapeutic instruments.

• His professional interests include cancer biology, epigenetic abnormalities, analysis of molecular alterations in cancer development, quantitative biology, genome operating systems, and the role of science and public policy, among others.

• In 1999 the Nature Biotechnology journal named Dr. Lizardi as one of the scientific researchers with greatest impact in the field of technological innovation due to his advances in the detection of DNA mutation in human genomes.

• He has served on professional organizations such as the American Chemical Society, American Association for the Advancement of Science, and the Editorial Board of Laboratory Investigation.

• Dr. Lizardi holds a bachelor’s degree from the University of Puerto Rico, a PhD from Rockefeller University in New York, and postdoctoral studies from the Carnegie Institution of Washington in Baltimore.